{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:57:10Z","timestamp":1792735030324,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.yjmcc.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T04:37:45Z","timestamp":1272256665000},"page":"196-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2"],"prefix":"10.1016","volume":"49","author":[{"given":"Kyriakos N.","family":"Papanicolaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo-o","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Herschman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2005.08.005","article-title":"Prostacyclin protects against elevated blood pressure and cardiac fibrosis","volume":"2","author":"Francois","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib5","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1073\/pnas.0805171105","article-title":"Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo","volume":"105","author":"Murata","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib6","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.0000128046.54681.97","article-title":"Prostaglandin E2 protects the heart from ischemia\u2013reperfusion injury via its receptor subtype EP4","volume":"109","author":"Xiao","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI200421446","article-title":"Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice","volume":"114","author":"Kobayashi","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1073\/pnas.0811834106","article-title":"Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1074\/jbc.M010603200","article-title":"Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling","volume":"276","author":"Scorrano","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"25219","DOI":"10.1074\/jbc.M310381200","article-title":"Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway","volume":"279","author":"Penzo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.bbabio.2006.03.024","article-title":"Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition","volume":"1757","author":"Di Paola","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.1068711","article-title":"Role of prostacyclin in the cardiovascular response to thromboxane A2","volume":"296","author":"Cheng","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib16","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"Fitzgerald","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib18","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1074\/jbc.274.8.5038","article-title":"Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1\/2-mediated induction of cyclooxygenase-2","volume":"274","author":"Adderley","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib19","doi-asserted-by":"crossref","first-page":"H2148","DOI":"10.1152\/ajpheart.00074.2007","article-title":"COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia","volume":"293","author":"Birkenmeier","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00424-007-0346-8","article-title":"Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes","volume":"455","author":"Hu","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.98.2.100","article-title":"Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure","volume":"98","author":"Wong","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib22","first-page":"222","article-title":"Cyclooxygenase-2 and nuclear factor-kappaB in myocardium of end stage human heart failure","volume":"5","author":"Saito","year":"1999","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/hrt.2003.010280","article-title":"Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?","volume":"90","author":"Abbate","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2004.04.002","article-title":"Inhibition of COX pathway in experimental myocardial infarction","volume":"37","author":"Saito","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.CIR.101.4.430","article-title":"Upregulation of COX-2 during cardiac allograft rejection","volume":"101","author":"Yang","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib26","doi-asserted-by":"crossref","first-page":"H1416","DOI":"10.1152\/ajpheart.00136.2003","article-title":"Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse","volume":"286","author":"LaPointe","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI200111334","article-title":"Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo","volume":"108","author":"Dowd","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.lfs.2005.04.060","article-title":"Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis","volume":"78","author":"Takahashi","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yjmcc.2008.11.011","article-title":"Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection","volume":"46","author":"Inserte","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib30","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1073\/pnas.97.18.10197","article-title":"Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits","volume":"97","author":"Shinmura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0008-6363(02)00414-5","article-title":"Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia\/reperfusion injury and mediates the late phase of preconditioning","volume":"55","author":"Bolli","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/378406a0","article-title":"Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II","volume":"378","author":"Dinchuk","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/hc4401.098429","article-title":"Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia\/reperfusion injury but are protected by acute preconditioning","volume":"104","author":"Camitta","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib34","doi-asserted-by":"crossref","first-page":"H532","DOI":"10.1152\/ajpheart.00863.2005","article-title":"Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin","volume":"291","author":"Neilan","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.106.647230","article-title":"Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig","volume":"115","author":"Timmers","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib36","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.2000.3010","article-title":"Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction","volume":"273","author":"Saito","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FJC.0b013e31804a5e50","article-title":"Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure","volume":"49","author":"Abbate","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib38","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.0000121354.34067.48","article-title":"Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure","volume":"109","author":"Delgado","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib39","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1073\/pnas.0805806106","article-title":"Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/gene.20192","article-title":"Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene","volume":"44","author":"Ishikawa","year":"2006","journal-title":"Genesis"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI119509","article-title":"Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo","volume":"100","author":"Agah","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib42","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1074\/jbc.273.2.1252","article-title":"Selective requirement of myosin light chain 2v in embryonic heart function","volume":"273","author":"Chen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","article-title":"Adiponectin protects against myocardial ischemia\u2013reperfusion injury through AMPK- and COX-2-dependent mechanisms","volume":"11","author":"Shibata","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib44","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","article-title":"Adiponectin-mediated modulation of hypertrophic signals in the heart","volume":"10","author":"Shibata","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.yjmcc.2007.03.808","article-title":"Adiponectin protects against the development of systolic dysfunction following myocardial infarction","volume":"42","author":"Shibata","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib46","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib47","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.872200","article-title":"Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury","volume":"120","author":"Oshima","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib48","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.febslet.2008.03.002","article-title":"Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes","volume":"582","author":"Ikeda","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib49","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/MCB.00126-09","article-title":"Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism","volume":"29","author":"Ohashi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)80542-5","article-title":"A perfect message: RNA surveillance and nonsense-mediated decay","volume":"96","author":"Hentze","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","article-title":"Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling","volume":"101","author":"Oka","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib53","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCRESAHA.107.159517","article-title":"Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart","volume":"102","author":"Snider","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib54","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and regulation of cyclooxygenase-2 during inflammation","volume":"106","author":"Simon","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib55","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","article-title":"Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction","volume":"94","author":"Harris","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","article-title":"Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse","volume":"83","author":"Morham","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase 2-deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib59","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/187152508783329948","article-title":"The role of COX-2 in heart pathology","volume":"6","author":"Streicher","year":"2008","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib61","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1073\/pnas.042390499","article-title":"Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3","volume":"99","author":"Gaussin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib62","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1161\/hc4301.098058","article-title":"Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia\u2013reperfusion injury: a study using mice lacking their respective receptors","volume":"104","author":"Xiao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib64","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","article-title":"Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function","volume":"116","author":"Cheng","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib65","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s003950070024","article-title":"Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice","volume":"95","author":"Guo","year":"2000","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib66","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.107.689810","article-title":"Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway","volume":"116","author":"Li","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/FJC.0b013e3181a7b5b6","article-title":"Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia\u2013reperfusion","volume":"53","author":"Salloum","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib68","first-page":"H308","article-title":"Eicosanoid synthesis in cardiomyocytes: influence of hypoxia, reoxygenation, and polyunsaturated fatty acids","volume":"268","author":"Oudot","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0952-3278(95)90116-7","article-title":"PAF effects on eicosanoid release in neonatal rat cardiomyocytes","volume":"53","author":"Becker","year":"1995","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1161\/hy02t2.102808","article-title":"Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes","volume":"39","author":"Mendez","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib71","doi-asserted-by":"crossref","first-page":"H2111","DOI":"10.1152\/ajpheart.00838.2004","article-title":"PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42\/44 MAPK and EGFR transactivation","volume":"288","author":"Mendez","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib72","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.107.716241","article-title":"Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells","volume":"117","author":"Fredenburgh","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib73","unstructured":"Streicher JM, Kamei K, Ishikawa TO, Herschman H, Wang Y. Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. J Mol Cell Cardiol."},{"key":"10.1016\/j.yjmcc.2010.04.002_bib74","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib75","doi-asserted-by":"crossref","unstructured":"Kakkar R, Lee RT. Intramyocardial fibroblast myocyte communication. Circ Res;106:47-57.","DOI":"10.1161\/CIRCRESAHA.109.207456"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.devcel.2008.12.007","article-title":"Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling","volume":"16","author":"Ieda","year":"2009","journal-title":"Dev Cell"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib77","doi-asserted-by":"crossref","first-page":"F1125","DOI":"10.1152\/ajprenal.00219.2004","article-title":"Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice","volume":"288","author":"Yang","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib78","doi-asserted-by":"crossref","first-page":"21565","DOI":"10.1074\/jbc.272.34.21565","article-title":"Mutational analysis of the role of the distal histidine and glutamine residues of prostaglandin-endoperoxide synthase-2 in peroxidase catalysis, hydroperoxide reduction, and cyclooxygenase activation","volume":"272","author":"Landino","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35011103","article-title":"Structural insights into the stereochemistry of the cyclooxygenase reaction","volume":"405","author":"Kiefer","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.biophys.32.110601.141906","article-title":"The structure of mammalian cyclooxygenases","volume":"32","author":"Garavito","year":"2003","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.109.198416","article-title":"Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models","author":"Koitabashi","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.04.002_bib82","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yjmcc.2008.09.002","article-title":"With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure","volume":"46","author":"Molkentin","year":"2009","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:18:59Z","timestamp":1758313139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282810001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022282810001410"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2010.04.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2010.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}